These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34164334)

  • 1. Identification of High-Risk of Recurrence in Clinical Stage I Non-Small Cell Lung Cancer.
    Tsutani Y; Shimada Y; Ito H; Miyata Y; Ikeda N; Nakayama H; Okada M
    Front Oncol; 2021; 11():622742. PubMed ID: 34164334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Segmentectomy for clinical stage IA lung adenocarcinoma showing solid dominance on radiology.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):637-42. PubMed ID: 24477740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressiveness.
    Mimae T; Miyata Y; Tsutani Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
    JTCVS Open; 2022 Sep; 11():300-316. PubMed ID: 36172403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of genetic status on the survival outcomes of patients with clinical stage I non-small cell lung cancer with a radiological pure-solid appearance.
    Sun K; Li M; Shang M; Su X; Zhao J; Wang B; Wu C; Zhang L; Yang S; Sun X
    Lung Cancer; 2022 Apr; 166():63-69. PubMed ID: 35196635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical T1aN0M0 lung cancer: differences in clinicopathological patterns and oncological outcomes based on the findings on high-resolution computed tomography.
    Sun K; You A; Wang B; Song N; Wan Z; Wu F; Zhao W; Zhou F; Li W
    Eur Radiol; 2021 Oct; 31(10):7353-7362. PubMed ID: 33860370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
    Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Risk Factors for Recurrence of Stage I Lung Adenocarcinoma: Follow-up Data From JCOG0201.
    Tsutani Y; Suzuki K; Koike T; Wakabayashi M; Mizutani T; Aokage K; Saji H; Nakagawa K; Zenke Y; Takamochi K; Ito H; Aoki T; Okami J; Yoshioka H; Okada M; Watanabe SI;
    Ann Thorac Surg; 2019 Nov; 108(5):1484-1490. PubMed ID: 31336067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm.
    Kagimoto A; Tsutani Y; Handa Y; Mimae T; Miyata Y; Okada M
    Jpn J Clin Oncol; 2020 Oct; 50(11):1306-1312. PubMed ID: 32901276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.
    Wang S; Zhang B; Qian J; Qiao R; Xu J; Zhang L; Zhao Y; Zhang Y; Wang R; Zhao R; Han B
    Lung Cancer; 2018 Nov; 125():245-252. PubMed ID: 30429028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2102-2110.e1. PubMed ID: 28947198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct clinicopathologic factors and prognosis based on the presence of ground-glass opacity components in patients with resected stage I non-small cell lung cancer.
    Wang C; Wu Y; Li J; Ren P; Gou Y; Shao J; Zhou Y; Xiao X; Tuersun P; Liu D; Zhang L; Li W
    Ann Transl Med; 2020 Sep; 8(18):1133. PubMed ID: 33240982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of segmentectomy versus lobectomy for radiologically pure solid or solid-dominant stage IA non-small cell lung cancer.
    Rao S; Ye L; Min L; Zhao G; Chen Y; Huang Y; Yang J; Xiao S; Cao R
    J Cardiothorac Surg; 2019 Nov; 14(1):197. PubMed ID: 31722726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomograms for Predicting Overall and Recurrence-free Survival From Pathologic Stage IA and IB Lung Cancer After Lobectomy.
    Merritt RE; Abdel-Rasoul M; Fitzgerald M; D'Souza DM; Kneuertz PJ
    Clin Lung Cancer; 2021 Jul; 22(4):e574-e583. PubMed ID: 33234491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Less is more in solid-dominant lung cancer? Sublobar resection versus lobectomy for solid-dominant stage IA non-small-cell lung cancer: A meta-analysis study.
    Guo J; Liu Y; Tian X; Ren Z; Lin J; Wang B; Liang C
    Mol Clin Oncol; 2019 Nov; 11(5):465-473. PubMed ID: 31620277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of comparing part-solid and pure-solid tumors in patients with clinical stage IA non-small-cell lung cancer in the eighth edition TNM classification.
    Jiang T; Li M; Lin M; Zhao M; Zhan C; Feng M
    Cancer Manag Res; 2019; 11():2951-2961. PubMed ID: 31114343
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk Factors of Recurrence in Patients With Clinical Stage IA Adenocarcinoma Presented as Ground-Glass Nodule.
    Su H; Dai C; Xie H; Ren Y; She Y; Kadeer X; Xie D; Zheng H; Jiang G; Chen C
    Clin Lung Cancer; 2018 Sep; 19(5):e609-e617. PubMed ID: 29803575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor size, but not consolidation-to-tumor ratio, is an independent prognostic factor for part-solid clinical T1 non-small cell lung cancer.
    Li Z; Xu W; Gu T; Cao X; Wu W; Chen L
    Thorac Cancer; 2023 Feb; 14(6):602-611. PubMed ID: 36578128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
    Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer with Radiologic Part-Solid or Solid Lesions.
    Fu F; Zhang Y; Wen Z; Zheng D; Gao Z; Han H; Deng L; Wang S; Liu Q; Li Y; Shen L; Shen X; Zhao Y; Zhao Z; Ye T; Xiang J; Zhang Y; Sun Y; Hu H; Chen H
    J Thorac Oncol; 2019 Dec; 14(12):2133-2142. PubMed ID: 31437531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.